Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$6.65 USD
+0.08 (1.14%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.64 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
KOD 6.65 +0.08(1.14%)
Will KOD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KOD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KOD
Why Is Kodiak Sciences (KOD) Up 10.5% Since Last Earnings Report?
Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus
KOD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD)
Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus
KOD Completes Enrollment in Phase III Study for Eye Disease Candidate
Other News for KOD
KOD Crosses Above Average Analyst Target
Kodiak Sciences (KOD) Shares Cross Above 200 DMA
Kodiak Sciences to Host Investor R&D Day on July 16, 2025 | KOD Stock News
Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular ...
Tracking Baker Brothers Portfolio - Q1 2025 Update